Payer Strategies to Manage the Impending Flood of Costly Specialty Drugs

Specialty drugs continue to dominate the pharma pipeline, which has literally hundreds of these high-cost therapies poised to hit the market. What steps can your organization take to attain an optimal balance between improved outcomes and soaring costs?

HTA and Market Insights.

Quintiles’ Complimentary webinar: HTA and Market Insights. Real-world evidence generation for evolving stakeholder needs. Register today.

eCOA in Diabetes Trials: Capturing Key Patient Data for All Stakeholders’ Needs

In this webinar, we will discuss how effective use of COAs can provide data that meets the needs of multiple stakeholders involved in diabetes clinical development programs – from patients and healthcare providers to regulators and payors.